Skip to content
Sign in

Company

PAI Pharma

Open structure map

Description

Headquarters
US

Structure of PAI Pharma

PAI Pharma

Company

4 connections
OwnershipInvestment and holdings
OwnProducts and technology
Relationship began2026
PAI PharmaCompany · 4 connections
Layer 1

OwnershipInvestment and holdings2

OwnProducts and technology2

Place in the network

No. 3930 of 104260top 4%

4 direct links

In a group of 5 closely linked entities, around

Sterile and ready-to-use pharmaceutical productsOlympus PartnersOral liquid medicinesNexus Pharmaceuticals, LLC

New links this week

Weighted by public relations with evidence, recomputed daily.

Relations

Money between companies

Who invests in, owns, acquires or finances whom, from the relations AiSeek holds with evidence.

Nexus Pharmaceuticals…acquiresPAI Pharma

From PAI Pharma

Lines show that a relation exists and which way it points; their thickness carries no amount. Dots only move to show the direction.

Arrows show the direction of the relationship. Filter to focus on a business area.

Showing 1 to 4 of 4

Claims

Read the assertion alongside its sources. Expand a row to inspect the evidence.

FactEvidence 1
acquiresNexus Pharmaceuticals, LLC

PAI Pharma ("PAI"), a portfolio company of Olympus Partners, and a leading U.S. developer, manufacturer, and marketer of oral liquid medicines, and Ready-To-Use ("RTU") sterile injectable and hospital-focused products, today announced the acquisition of Nexus Pharmaceuticals, LL…

PR Newswire news releases · 2026-11-13 02:00

View evidence
  • CompanyPR Newswire news releases2026-11-13 02:00
    PAI Pharma ("PAI"), a portfolio company of Olympus Partners, and a leading U.S. developer, manufacturer, and marketer of oral liquid medicines, and Ready-To-Use ("RTU") sterile injectable and hospital-focused products, today announced the acquisition of Nexus Pharmaceuticals, LL…
    View source
FactEvidence 1
part ofOlympus Partners

PAI Pharma, a portfolio company of Olympus Partners.

PR Newswire news releases · 2026-11-13 02:00

View evidence
  • CompanyPR Newswire news releases2026-11-13 02:00
    PAI Pharma, a portfolio company of Olympus Partners.
    View source
FactEvidence 1
manufacturesOral liquid medicines

PAI Pharma, headquartered in Parsippany, NJ, is a leading U.S. pharmaceutical company specializing in the development, manufacturing, and marketing of high-quality oral liquid, sterile and ready-to-use pharmaceutical products.

PR Newswire news releases · 2026-11-13 02:00

View evidence
  • CompanyPR Newswire news releases2026-11-13 02:00
    PAI Pharma, headquartered in Parsippany, NJ, is a leading U.S. pharmaceutical company specializing in the development, manufacturing, and marketing of high-quality oral liquid, sterile and ready-to-use pharmaceutical products.
    View source
FactEvidence 1
manufacturesSterile and ready-to-use pharmaceutical products

PAI Pharma, headquartered in Parsippany, NJ, is a leading U.S. pharmaceutical company specializing in the development, manufacturing, and marketing of high-quality oral liquid, sterile and ready-to-use pharmaceutical products.

PR Newswire news releases · 2026-11-13 02:00

View evidence
  • CompanyPR Newswire news releases2026-11-13 02:00
    PAI Pharma, headquartered in Parsippany, NJ, is a leading U.S. pharmaceutical company specializing in the development, manufacturing, and marketing of high-quality oral liquid, sterile and ready-to-use pharmaceutical products.
    View source

Showing 1 to 4 of 4

Market and valuation

Valuation data is available on Pro and Research.

Included in Pro

Suggest a page to watch

Know a page of this company that matters, such as pricing, a changelog, terms or careers? Suggest it. We read every suggestion; a page we add is watched for everyone, and we only count a change when two looks in a row agree.

Sign in to suggest a page

Not available: Company signals · Financials · Filings · Sites · Guidance